Humacyte (HUMA) Accumulated Depreciation (2020 - 2025)
Humacyte (HUMA) posted quarterly Accumulated Depreciation of $41.3 million for Q4 2025, up 14.53% year-over-year from $36.1 million in Q4 2024, and up 14.53% quarter-over-quarter from $36.1 million in Q4 2024.
Humacyte (HUMA) Accumulated Depreciation (2020 - 2025) Analysis & Trends
Humacyte (HUMA) has reported Accumulated Depreciation for 4 consecutive years, with $41.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Accumulated Depreciation rose 14.53% year-over-year to $41.3 million; the TTM figure through Dec 2025 stood at $41.3 million (up 14.53% YoY), while the FY2025 annual figure was $41.3 million, up 14.53% from the prior year.
- Accumulated Depreciation advanced to $41.3 million in Q4 2025 per HUMA's latest filing, from $36.1 million in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $41.3 million in Q4 2025 and bottomed at $18.9 million in Q3 2021.
- Historically, Accumulated Depreciation has averaged $32.1 million across 3 years, with a median of $36.1 million in 2024.
- On a YoY basis, Accumulated Depreciation climbed as much as 14.53% in 2025 and fell as far as 14.53% in 2025.
- Humacyte's Accumulated Depreciation stood at $18.9 million in 2021, then surged by 90.83% to $36.1 million in 2024, then grew by 14.53% to $41.3 million in 2025.
- Business Quant data shows HUMA's Accumulated Depreciation at $41.3 million in Q4 2025, $36.1 million in Q4 2024, and $18.9 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | Humacyte | 154.16 Mn | 154.16 Mn | -825,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41.33 Mn |
| Dec 31, 2024 | 36.09 Mn |
| Sep 30, 2021 | 18.91 Mn |
| Dec 31, 2020 | 14.26 Mn |